Oxytocin receptor is a promising therapeutic target of malignant mesothelioma. Kodama Y, Tanaka I, Sato T, Hori K, et al. Cancer Sci 2021;112:3520-3532.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kodama Y, Tanaka I, Sato T, Hori K, et al. Oxytocin receptor is a promising therapeutic target of malignant mesothelioma. Cancer Sci 2021;112:3520-3532.
PMID: 34115916